Gammopathy pp 213-233 | Cite as

Organ destructive effect of the light chains. Myeloma kidney

  • János Jákó


Apart from infections, renal insufficiency is the most frequent cause of death in patients with monoclonal gammopathy (5, 8, 23, 87). Renal destruction develops very slowly, whereas the main disease still remains “lsymptom free”. Explanation of both clinical findings and their relationship is discussed.


Multiple Myeloma Light Chain Plasma Exchange Distal Tubule Renal Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Argani, I., Kipkie, G. F. Macroglobulinemic nephropathia. Acute renal failure in macroglobulinemia of Waldenström. Amer. J. Med. 36, 151. 1964.PubMedCrossRefGoogle Scholar
  2. 2.
    Avasthi,P. S.,Erickson,D.G.,Williams,R.C.,Tung,K. S.K. Benign monoclonal gammaglobulinemia and glomerulo-nephritis. Amer. J. Med. 62, 324. 1977.CrossRefGoogle Scholar
  3. 3.
    Baglioni, C, Cioli, D., Gorini, G. Studies on fragments of light chains of human immunoglobulins: genetic and biochemical implications. Cold Spring. Harbor Symp. Quant. Biol. 32, 147. 1967.CrossRefGoogle Scholar
  4. 4.
    Baldwin, D. S., McCluskey, R. T. Renal involvement in systemic lupus erythematosus, periar-teritis nodosa, scleroderma, and cryoglobulinemia. In: Structural basis of Renal Disease. Ed: by Bekre, A. L. New York, Harper and Row. 428. 1968.Google Scholar
  5. 5.
    Balogh, E., Krizsa, F., Varga, Gy., Cserháti, J., Husz, S. Myeloma multiplexben szerzett tapasztalataink 25 beteg ász-lelese során. Orv. Hetilap. 121, 2505. 1980.Google Scholar
  6. 6.
    Bargenter, A. R., Murphy, W. M. Kappa light chain nepropathy. Wirchow Arch. A. 410, 531. 1987.Google Scholar
  7. 7.
    Bauer, H. J., Lamerz, R., Gokel, J. M., Remberger, K. Bence Jones Proteinämie und Amyloidosis. Münch. med. Wschr. 118, 361. 1976.Google Scholar
  8. 8.
    Bayrd, E. D.,Heck, F. J. Multiple myeloma: Review of eighty-three proved cases. J. Amer. Med. Ass. 133, 147. 1947.CrossRefGoogle Scholar
  9. 9.
    Beaufils, M., Morel-Maroger, L. Pathogenesis of renal disease in monoclonal gammopathies: current concepts. Nephron. 20, 125. 1975.CrossRefGoogle Scholar
  10. 10.
    Berdon, W. E., Schwartz, R. H., Becker, J. Tamm-Horsfall proteinuria. Radiology. 92, 714. 1969.PubMedGoogle Scholar
  11. 11.
    Bergesio, F., Salvatori, M., Lombardi, M., Mishelassi, S., Salerno, A., Lmreh, F., Guidi, S., Mousoui, G., Florian, A. Renal involvement in IgD myeloma. Scand. J. Urol. Nephrol. 22, 309. 1988.PubMedCrossRefGoogle Scholar
  12. 12.
    Berkel, J., Granillo-Bodansky, C, Borne, A. E. G. Acute renal failure associated with a malignant lymphoproliferative disorder with monoclonal light chain immunoglobulin production. Scand, J. Haematol. 20, 377. 1978.CrossRefGoogle Scholar
  13. 13.
    Berkessy, S., Balyi, G., Molnar I., Nagy, Zs., Pauker, Zs., Radványi, G., Végh, I. Tapasztalataink myeloma multiplexben. Orv. Hetilap. 128, 1975. 1987.Google Scholar
  14. 14.
    Bernier, G. M., Putnam, F. W. Monomer-dimer forms of Bence Jones proteins. Nature. 200, 223. 1963.PubMedCrossRefGoogle Scholar
  15. 15.
    Bernier, G. M., Fanger, M. W. Synthesis of beta-2-microglobulin by stimulated lymphocytes. J. Immunol. 109, 407. 1972.PubMedGoogle Scholar
  16. 16.
    Bienenstock, J., Poortmans, J. Synthesis and assembly of IgA and other urinary proteins. In: Protides of the Biological Fluids 21st Colloquium. Ed: by Peeters, H. Pergamon Press. 104. 1973.Google Scholar
  17. 17.
    Bloch, K. J. Gamma heavy chain disease: An expanding clinical and laboratory spectrum. Amer. J. Med. 55, 61. 1973.PubMedCrossRefGoogle Scholar
  18. 18.
    Boros, Gy., Gofman, L., Romhanyi, M., Ambrus, M., Otto, Sz.,Deák, Gy. Kryoglobulinaemia, illetve kryofibrinogenaemia és vese. Orv. Hetilap. 115,1048. 1974.Google Scholar
  19. 19.
    Brovet, J. C, Clauvel, J. P., Danon, F., Klein, M., Seligman, M. Biologic and clinical significance of cryoglobulins. Amer. J. Med. 57, 775. 1974.CrossRefGoogle Scholar
  20. 20.
    Burke, F. J., Flis, R., Lasker, N., Simenhoff, M. Malignant lymphoma with „myeloma kidney” acute renal failure. Amer. J. Med. 60, 1055. 1976.PubMedCrossRefGoogle Scholar
  21. 21.
    Butler, W. T., Rossen, R. D. Effects of corticostreroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high does of methylprednisolone. J.Clin. Invest.52, 2629. 1973.PubMedCrossRefGoogle Scholar
  22. 22.
    Butler, W. T., Couch, R. B., Rossen, R. D. Methlyprednisolone fails to inhibit primary and secondary antibody responses but causes marked suppression of ongoing antibody formation in man. J. Clin. Invest. 53, 14. 1974.CrossRefGoogle Scholar
  23. 23.
    Carson, C. P., Ackerman, L. V., Maltby, J. D. Plasma cell myeloma: Clinical, pathologic, and roentgenologic review of 90 cases. Amer. J. Clin. Path. 25, 849. 1955.Google Scholar
  24. 24.
    Clyne, D. H., Brendstrup, B., First, M. R., Pesce, A. J., Finkel, P. N., Pollah, V. E., Pirani, C. R. Renal effects of intraperitoneal kappa chain infection. Induction of crystals in renal tubular cells. Lab. Invest. 31, 131. 1974.PubMedGoogle Scholar
  25. 25.
    Constanza, D. J., Smoller, M. Multiple myeloma with Fanconi syndrome. Study of a case, with electron microscopy of the kidney. Amer. J. Med. 34, 125. 1963.CrossRefGoogle Scholar
  26. 26.
    Coward, R. A., Delamore, I. W., Mallick, N. P., Robinson, E. L. The Importance of urinary immunoglobulin light chain isoelectric point (pJ) in nephrotoxicity in multiple myeloma. Clin. Sci. 66, 229. 1984.PubMedGoogle Scholar
  27. 27.
    Dammacco, F., Waldenström, J. Bence Jones proteinuria in benign monoclonal gammo-pathies: incidence and characteristics. Acta. Med. Scand. 184, 403. 1968.PubMedCrossRefGoogle Scholar
  28. 28.
    DeFronzo, R. A., Cooke, C. R., Wright, J. R. Bence Jones proteinuria and renal failure in multiple myeloma. Clin. Res. 22, 486. 1974.Google Scholar
  29. 29.
    DeFronzo, R. A., Humprey, R. L., Wright, J. R., Cooke, C.R. Acute renal failure in multiple myeloma. Medicine. 54, 208. 1975.CrossRefGoogle Scholar
  30. 30.
    DeFronzo, R. A., Cooke, C. R., Wright, J. R., Humphrey, R. L. Renal function in patients with multiple myeloma. Medicine. 57, 151. 1978.PubMedCrossRefGoogle Scholar
  31. 31.
    Doyle, G. D., O’Dwyer, W. F., Carmody, M., Cambell, Eileen, Browne, O. IgA nephropathy — an immunpathological study. Irish J. Med. Sci. 145, 292. 1976.PubMedCrossRefGoogle Scholar
  32. 32.
    Druet, P., Letonturier, P., Contet, P., Mandet, C. Cryoglobulinaemia in human renal diseases. A study of seventy-six cases. Clin. Exp. Immunol. 15, 483. 1973.PubMedGoogle Scholar
  33. 33.
    Edelman, G. M., Gaily, J. A. The nature of Bence Jones proteins: chemical similarities to polypeptide chains of myeloma globulins and normal gam-maglobulins. J. Exp. Med. 116, 207. 1962.PubMedCrossRefGoogle Scholar
  34. 34.
    Engle, R. L. Jr., Wallis, L. A. Multiple myeloma and adult Fanconi syndrome: I. Report of a case with crystal-like deposit in the tumor cells and in the epithelial cells of the kidney. Amer. J. Med. 22, 5. 1957.PubMedCrossRefGoogle Scholar
  35. 35.
    Fine, J. D., Rees, E. D. Renal cytotoxic effects of Bence Jones proteins. Lancet i. 150. 1977.CrossRefGoogle Scholar
  36. 36.
    Fletcher, A. P., McLanghlin, J. E., Ratcliffe, W. A., Woods, DA. The chemical composition and electron microscopic appearance of a protein derived from urinary casts. Biochim, biophys. Acta. 214, 299. 1970.Google Scholar
  37. 37.
    Forte, F. A. Heavy chain disease of the μ/gamma M/type: Report of the first case. Blood. 36, 137. 1970.PubMedGoogle Scholar
  38. 38.
    Frangione, B., Franklin, E. C. Heavy chain disease: Clinical features and molecular significante of the disordered immunoglobulin structure. Semin. Hematol. 1, 53. 1973.Google Scholar
  39. 39.
    Franklin, E. C. Physicochemical an immunologic studies of gammaglobulins of normal human urine. J. Clin-Invest. 38, 2159. 1959.PubMedCrossRefGoogle Scholar
  40. 40.
    Franklin, E. C. Heavy chain disease: A new disorder of serum gammaglobulins. Report of a first case. Amer. J. Med. 37, 332. 1964.PubMedCrossRefGoogle Scholar
  41. 41.
    Franklin, E. C. Mü-chain disease. Arch. Intern. Med. 135, 71. 1975.PubMedCrossRefGoogle Scholar
  42. 42.
    Golde, D., Epstein, W. Mixed cryoglobulins and glomerulonephritis. Ann. Intern. Med. 69, 1221. 1968.PubMedGoogle Scholar
  43. 43.
    Green, R. W. Conformation and association of the light chain from a homogeneous human immunoglobulin. Biochemistry. 12, 3225. 1973.PubMedCrossRefGoogle Scholar
  44. 44.
    Grey, H. M., Kohler, P. F. A case of tetramer Bence Jones proteinaemia. Clin. Exp. Immunol. 3, 277. 1968.PubMedGoogle Scholar
  45. 45.
    Grey, H. M., Kohler, P. F. Cryoimmunoglobulins. Semin. Hematol. 10, 87. 1973.PubMedGoogle Scholar
  46. 46.
    Hardwicke, J Glomerular filtration of macromolecules. Adv. Nephrol. 2, 61. 1972.Google Scholar
  47. 47.
    Harrison, J. F., Blainey, J. D. Adult Fanconi syndrome with monoclonal abnormality of immunoglobulin light chain. J. Clin. Path. 20, 42. 1967.PubMedCrossRefGoogle Scholar
  48. 48.
    Harrison, J. F., Lunt, G. S., Scott, P. Urinary lysozyme, ribonuclease and low molecular weight protein in renal disease. Lancet, i. 371. 1968.CrossRefGoogle Scholar
  49. 49.
    Hobbs, J. R., Evans, D. J., Wrong, O. M. Renal tubular obstruction by mucoproteins from adenocarcinoma of pancreas. Brit. Med. J. 2, 87. 1974.PubMedCrossRefGoogle Scholar
  50. 50.
    Hobbs, J. R. Monitoring myelomatosis. Arch. Intern. Med. 135,125. 1975.PubMedCrossRefGoogle Scholar
  51. 51.
    Hymans, W. Waldenström’s disease with an IgA paraprotein. Acta Med. Scand. 198, 519. 1975.Google Scholar
  52. 52.
    Iványi, B. A myeloma multiplex veseszövödményei. Orv. Hetilap. 38, 2041. 1989.Google Scholar
  53. 53.
    Jákó,J.,Virágh,Sz. Nierenschädigung durch Lambda-Leichtketten. J. Donausymposium für Nephrologie.Linz. 252. 1976.Google Scholar
  54. 54.
    Jákó,J., Virãgh,Sz. Nierenerkrankungen bei monoklonalen Gammopathien. Eine klinisch-pathologische Studie. Immunität und Infektion. 9, 60. 1981.PubMedGoogle Scholar
  55. 55.
    Jensen, K. Two Bence Jones proteins in a macroglobulinaemic patient. Scand. J. Clin. Lab. Invest. 26, 23. 1970.PubMedCrossRefGoogle Scholar
  56. 56.
    Jensen, H.,Wiik, A. Monoclonal immunoglobulinemia associated with glomerulopathy. Acta Med. Scand. 197, 265. 1975.PubMedCrossRefGoogle Scholar
  57. 57.
    Jones, H. B. On a new substance occurring in the urine of a patient with mollities ossium. Philos. Trans. R. Soc. London. 55, 62. 1848.Google Scholar
  58. 58.
    Kahler, O. Zur Symptomatologie des multiplen Myelomas: Beobachtung von Albumosurie. Prag. med. Wochenschr. 14, 33. 1889.Google Scholar
  59. 59.
    Kamm, D. E., Fisher, M. S. Proximal renal tubular acidosis and the Fanconi syndrome in a patient with hypergammaglobulinemia. Nephron. 9, 208. 1972.PubMedCrossRefGoogle Scholar
  60. 60.
    Kin, K., Sakurabayashi, I., Kawai, T. Beta-2 mikroglobulin levels of serum and ascites in malignant diseases. Gann. 68, 427. 1977.PubMedGoogle Scholar
  61. 61.
    Kirkpatrick, C. J., Gurry, A., Galle, J., Melzner, J. Systhemic kappa light chain deposition and amyloidosis in multiple myeloma: novel morphological observation. Histopathology. 10, 1065. 1986.PubMedCrossRefGoogle Scholar
  62. 62.
    Koss, M. N., Pirani, C., Osserman, E. F. Experimental Bence Jones cast nephropathy. Lab. Invest. 34, 579. 1976.PubMedGoogle Scholar
  63. 63.
    Kyle, R. A., Maldonado, J. E., Bayrd, E. D. Idiopathic Bence Jones proteinuria: a distinct entity. Amer. J. Med. 55, 222. 1973.PubMedCrossRefGoogle Scholar
  64. 64.
    Kyle, R. A. Multiple myeloma: review of 869 cases. Mayo Clin. Proc. 50, 29. 1975.PubMedGoogle Scholar
  65. 65.
    Lapis K., Beregi E. A vesebetegségek klinikopathológiája. Akadémia Kiadó. Budapest. 149. 1988.Google Scholar
  66. 66.
    Larcan, A. Syndrome néphrotique et maladie de Kahler. A propos de 5 observations. Sem. Hop. Paris. 40, 69. 1964.Google Scholar
  67. 67.
    Lawler, W., Tarpex, P., Williams, G., Acheson, E. J., Mallick, N. P. Diseases and histological normality of the renal glomerulus: a clinico-pathological study. J. Clin. Path. 29, 380. 1976.PubMedCrossRefGoogle Scholar
  68. 68.
    Leathern, A., Wiggins, R. Cryoglobulins in urine. Clin. Chim. Acta. 71, 353. 1976.CrossRefGoogle Scholar
  69. 69.
    Lee,D.B.N.,Drinkard,J.P.,Rosen,V.J.,Gonick,K.C. The adult Fanconi syndrome. Medicine. 51,107. 1972.PubMedCrossRefGoogle Scholar
  70. 70.
    Levi, D. F., Williams, R. C, Linstrom, F. D. Immunofluerescent studies of the myeloma kidney with special reference to light chain disease. Amer. J. Med. 44, 922. 1968.PubMedCrossRefGoogle Scholar
  71. 71.
    Lindeman, R. D. Drug treatment of the chronic idiopathic glomerulopathies. Postgrad. Med. 62, 135. 1977.PubMedGoogle Scholar
  72. 72.
    Maack, T. Renal handling of low molecular weight proteins. Amer. J. Med. 58, 57. 1975.PubMedCrossRefGoogle Scholar
  73. 73.
    Maclntyre, W. Case of mollities and fragilitas ossium accompanied with urine strongly charged with animal matter. Med. Chir. Soc. Tr. 33, 211. 1850.Google Scholar
  74. 74.
    Maldonado, J. E., Velosa, J. A., Kyle, R. A., Wagoner, R. D., Holley, K. E., Salassa, R. M. Fanconi syndrome in adults. A manifestation of a latens form of myeloma. Amer. J. Med. 58, 354. 1975.PubMedCrossRefGoogle Scholar
  75. 75.
    Mallick, N. P., Dosa, S., Acheson, E. J., Delamore, I. W., McFarlane, H., Seneviratne, C. J., Williams, G. Detection significance and treatment of paraprotein in patients with „idiopathic” proteinuria without myeloma. Quat. J. Med. 47, 186. 1977.Google Scholar
  76. 76.
    Manuel, Y., Greenland, T. B. Immunoelectrophoresis: a convenient method of studying „minimal changes” in proteinuria. In: Protides of the Biological Fluids 21st Colloquium. Ed: by Peeters, H. Pergamon Press. 393. 1973.Google Scholar
  77. 77.
    Manuel, Y., Leclercq, M., Colle, A., Tonnelle, C. Low molecular weight proteins in tubular proteinuria. In: Protides of the Biological Fluids 21st Colloquium. Ed.: by Peeters, H. Pergamon Press. 505. 1973.Google Scholar
  78. 78.
    Manuel, Y., Colle, A., Leclercq, M., Tonnelle, C. Low molecular weight proteinuria. Contributions to Nephrology. 1, 156. 1975.PubMedGoogle Scholar
  79. 79.
    Martinez-Maldonado, M., Yium, J., Sulo, W. N., Eknoyan, G. Renal complications in multiple myeloma: pathophysiology and some aspects of clinical management. J.Chron.Dis. 24,221. 1971.PubMedCrossRefGoogle Scholar
  80. 80.
    Mauer, S. M., Fich, A. J., Day, N. K., Michael, A. F. The glomerular mesangium. II. Studies of macromolecular uptake in nephrotoxic nepritis in rats. J. Clin. Invest. 53, 4321. 1974.CrossRefGoogle Scholar
  81. 81.
    McCoy, R. C, Abromowsky, C. R., Tisher, C. C. IgA-nephropathy. Amer. J. Path. 76,123. 1974.PubMedGoogle Scholar
  82. 82.
    McGiven, A. R., Hunt, J. S., Day, W. A., Bailey, R. R. Tamm-Horsfall protein in the glomerular capsular space. J. Clin. Path. 31, 620. 1978.PubMedCrossRefGoogle Scholar
  83. 83.
    McLaughlin, C. L., Solomon, A. A hidden antigenic site localized to the constant region of light chains of immunoglobulins. Science. 179, 580. 1973.PubMedCrossRefGoogle Scholar
  84. 84.
    Meyer, F. In vitro incorporation of C14-lysine into Bence Jones protein. Proc. Soc. Exp. Biol. 110, 106. 1962.PubMedGoogle Scholar
  85. 85.
    Miano, L. Le proteinurie infantili. Inquandramento clinico-patogenetico. Progr. Med. Roma. 30, 357. 1974.Google Scholar
  86. 86.
    Min, K. W., Cain, D. G., Gyorkey, Ph., Györkey, F. Myeloma-like lesions of the kidney. Amer. Med. Assoc. 136, 1299. 1976.Google Scholar
  87. 87.
    Miszlai, Zs., Olasz, É., Nagy, I., Losonczy, H., Jávor, T. Myeloma multiplexben szenvedõ betegeink adatelemzése 1977–85 között. Orv. Hetilap. 128, 297. 1987.Google Scholar
  88. 88.
    Monga, G., Mazzucco, G., Coppo, R., Piccoli, G., Coda, R. Glomerular finding in mixed IgG-IgM cryoglobulinemia. Virschows Arch. B. Cell. Path. 20, 185. 1976.Google Scholar
  89. 89.
    Morel-Maroger, L., Basch, A., Danon, F., Verroust, P., Richet, G. Pathology of the kidney in Waldenström’s. N. Engl. J. Med. 283, 123. 1970.PubMedCrossRefGoogle Scholar
  90. 90.
    Morris, R. C, Sebastian, A., McSherry, E. Renal acidosis. Kidney Int. 1,332. 1972.CrossRefGoogle Scholar
  91. 91.
    Nakamuro, K., Tanigaki, N., Pressman, D. Multiple common properties of human beta-2-microglobulin and the common portion fragment derived from HL-A antigen molecules. Proc. Nat. Acad. Sci. 70, 2863. 1973.PubMedCrossRefGoogle Scholar
  92. 92.
    Neauport-Sautes, C, Bismuth, A., Kourilsky, F., Manuel, Y. Relationship between HL-A antigens and beta-2-microglobulin as studied by immunofluorescence on the lymphocyte membrane. J. Exp. Med. 139, 957. 1974.PubMedCrossRefGoogle Scholar
  93. 93.
    Noel, L. H., Droz, D., Gavenal, D., Grünfeld, J. P. Renal granular monoclonal light chain deposits. Clin. Nephrology. 21, 263. 1984.Google Scholar
  94. 94.
    Norden, A. G. W., Flynn, F. V., Fulcher, L. M., Richards, J. D. M. Renal impairment in myeloma: negativ accosiation with isoelectric point of excreted Bence Jones protein. J. Clin. Pathol. 42, 59. 1989.PubMedCrossRefGoogle Scholar
  95. 95.
    Osserman, E. F. Plasma cell myeloma: II. Clinical aspects. N. Engl. J. Med. 261, 1006. 1959.PubMedCrossRefGoogle Scholar
  96. 96.
    Osserman, E. F., Takatsuki, K. Clinical and immunochemical studies of four cases of heavy (H gamma-2) chain disease. Amer. J. Med. 37, 351. 1964.PubMedCrossRefGoogle Scholar
  97. 97.
    Osterland, C. K., Espinoza, L. R. Biological properties of myeloma proteins. Arch. Intern. Med. 135, 32. 1975.PubMedCrossRefGoogle Scholar
  98. 98.
    Palant, C. E., Bonitati, J., Bartholomew, W. R., Bretjens, J. R. Nodular glomerulosclerosis associated with multiplex myeloma. Amer. J. Med. 80, 98. 1986.PubMedCrossRefGoogle Scholar
  99. 99.
    Parr, D. M., Pruzanski, W., Scott, J. G., Mills, D. M. Primary amyloidosis with plasmacytic dyscrasia and a tetra-mer of Bence Jones type lambda globulin in the serum and urine. Blood. 37, 473. 1971.PubMedGoogle Scholar
  100. 100.
    Perry, M. C, Kyle, R. A. The clinical singificance of Bence Jones proteinuria. Mayo Clin. Proc. 50, 234. 1975.PubMedGoogle Scholar
  101. 101.
    Peterson, P. A., Cunningham, B. A., Berggard, I., Edelman, G. M. Beta-2 microglobulin. A free immunoglobulin domain. Proc. Nat. Acad. Sci. 69, 1967. 1972.CrossRefGoogle Scholar
  102. 102.
    Poortmans, J. R., Jeanloz, R. W., Schmid, K. 3 S gamma-1 globulin levels of normal human serum and urine. Biochim. Biophys. Acta. 133, 363. 1967.PubMedGoogle Scholar
  103. 103.
    Preuss, H. G., Hammack, W. J., Murdaugh, H. V. The effect of Bence Jones protein on the in vitro function of rabbit renal cortex. Nephron. 5,210. 1967.CrossRefGoogle Scholar
  104. 104.
    Preuss, H. G., Weiss, F. R., Tammarino, R. M., Hammack, W. J., Murdaugh, H. V. Effects of rat kidney slice function in vitro of proteins from the urines of patients with myelomatosis and nephrosis. Clin. Sci. Mol. Med. 46, 283. 1974.PubMedGoogle Scholar
  105. 105.
    Pruzanski, W. Clinical manifestations of multiple myeloma: relation to class and type of M component. Can. Med. Ass. J. 114, 896. 1976.PubMedGoogle Scholar
  106. 106.
    Putnam, R. W., Hardy, S. Proteins in multiple myeloma: III. Origin of Bence Jones protein. J. Biol. Chem. 212, 361. 1955.PubMedGoogle Scholar
  107. 107.
    Randall, R. E., Williamson, C. Jr., Mullinax, F., Tung, M. Y., Still, W. J. Manifestations of systemic light chain deposition. Amer. J. Med. 60, 293. 1976.PubMedCrossRefGoogle Scholar
  108. 108.
    Renner, E. Glomeruläre Filtration und nephrotisches Syndrom. In Klinische Pathophysiologie. Ed. by K. Siegenthaler. Thieme. Stuttgart 3, 865. 1976.Google Scholar
  109. 109.
    Rota, S., Mougenot, B., Baudouin, B., de Meyer-Brausseur, M., Lemaitre, V., Michel, C. Multiple myeloma and severe Renal Failure: A clinicopathologic study of outcome and prognosis in 34 patients. Medicine. 66, 126. 1987.PubMedCrossRefGoogle Scholar
  110. 110.
    Sandres, P. W., Herrera, G. A., Chen, Ann, Booker, B. B., Galla, J. H. Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo. J. Clin. Invest. 82, 2086. 1988.CrossRefGoogle Scholar
  111. 111.
    Scarlett, J. D., Wiley, J. S., Miach, P. J. Long-term survival in light-chain myeloma with renal failure. Aust. N. Z. J. Med. 15, 361. 1985.PubMedCrossRefGoogle Scholar
  112. 112.
    Schenk, E. A., Schwarz, R. H., Lewis, R. A. Tamm-Horsfall mucoprotein. 1. Localization in the kidney. Lab. Invest. 25, 92. 1971.PubMedGoogle Scholar
  113. 113.
    Schubert, S. E., Adam, A. Glomerular nodules and long-spacing collagen in kidneys of patients with multiple myeloma. J. Clin. Path. 27, 800. 1974.PubMedCrossRefGoogle Scholar
  114. 114.
    Schubert, G. E., Veigel, J., Lennert, K. Structure and function of the kidney in multiple myeloma. Virchows Archs. Path. Anat. 335, 135. 1972.Google Scholar
  115. 115.
    Seligmann, M. Alpha chain disease: A new immunoglobulin abnormality. Science. 162,1396. 1968.PubMedCrossRefGoogle Scholar
  116. 116.
    Seligmann, M., Clauvel, J. P. Données actuelles sur les proliférations de cellules B et les dysglobulinémies. Actualités Néphrologiques de l’Hospital, Necker. Medicales Flammarion. Paris. 289. 1977.Google Scholar
  117. 117.
    Seon, B-K., Grossberg, A. L., Roholt, O. A. Position of the selective peptic cleavage of a human kappa-chain between the V-kappa and C-kappa domains. J. Immunol. 111,269. 1973.PubMedGoogle Scholar
  118. 118.
    Shustik, C, Bergsagel, D. E., Pruzanski, W. Kappa and lambda light chain disease: survival rate and clinical manifestations. Blood. 48,41. 1976.PubMedGoogle Scholar
  119. 119.
    Smithline, N., Kassirer, J. P., Cohen, J. J. Light chain nepropathy: tubular dysfunction. N. Engl. J. Med. 294,71. 1976.PubMedCrossRefGoogle Scholar
  120. 120.
    Snapper, I., Kahn, A. Myelomatosis: Fundamentals and clinical features. Baltimore, University Park Press. 189. 1971.Google Scholar
  121. 121.
    Sobel, A. T., Antonucci, M., Intrator, L., Bernard, D., Beaumont, J. L., Lagrue, G. Association d’une gammapathie monoclonale, d’une glomé- rulopathie chronique et d’une hyperlipidémie. Nouv. Presse Méd. 5, 2375. 1976.PubMedGoogle Scholar
  122. 122.
    Solomon, A., Fahey, J. L., Malmgren, R. A. Immunohistologic localization of gamma-1 macroglobulins, beta-2A myeloma proteins, 6,6 S gamma myeloma proteins and Bence Jones proteins. Blood. 21,403. 1963.PubMedGoogle Scholar
  123. 123.
    Solomon, A., Fahey, J. L., Metabolism of Bence Jones proteins. Amer. J. Med. 37, 206. 1964.PubMedCrossRefGoogle Scholar
  124. 124.
    Solomon, A., Waldman, T. A., Fahey, J. L., McFarlane, A. S. Metabolism of Bence Jones protein. J. Clin. Invest. 43, 103. 1964.PubMedCrossRefGoogle Scholar
  125. 125.
    Solomon, A., Killander, J., Gray, H. M. Low-molecular-weight proteins related to Bence Jones proteins in multiple myeloma. Science. 151, 1237. 1966.PubMedCrossRefGoogle Scholar
  126. 126.
    Solomon, A., McLaughlin, C. L. Bence Jones proteins and light chains of immunoglobulins. I. Formation and characterization of amino-terminal (variant) and carboxyl-terminal (constant) halves. J. Biol. Chem. 244, 3393. 1969.PubMedGoogle Scholar
  127. 127.
    Solomon, A. Bence Jones protein: a molecular entity for studies on the structural and genetic control of antibody specificity. Mt. Sinai. J. Med. N. Y. 37, 466. 1970.Google Scholar
  128. 128.
    Solomon, A., McLaughlin, C. L,. Capra, J. D. Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy. J. Clin. Invest. 55, 579. 1975.PubMedCrossRefGoogle Scholar
  129. 129.
    Solomon, A. Bence Jones proteins and light chains of immunoglobulins. N. Engl. J. Med. 294, 17. 1976.PubMedCrossRefGoogle Scholar
  130. 130.
    Sox, H. C. Jr., Hood, L. Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chain. Proc. Nat. Acad. Sci. 66, 975. 1970.PubMedCrossRefGoogle Scholar
  131. 131.
    Squire, J.R., Blainey, J. D., Hardwicke, J. The nephrotic syndrome. Brit. Med. Bull. 13, 43. 1957.PubMedGoogle Scholar
  132. 132.
    Stekhoven, Sch., Haelst, J. H., Van. U. JG. M. Unusual findings in the human renal glomerulus in multiple myeloma. A light- and electron-microscopyc study. Cell. Path. 9,311. 1971.Google Scholar
  133. 133.
    Stevenson, G. T. Detection in normal urine or protein resembling Bence Jones protein. J. Clin. Invest. 39, 1192. 1960.PubMedCrossRefGoogle Scholar
  134. 134.
    Strife, C. F., McDonald, B. M., Ruley, E. J., McAdams, A. J.,. West, C. D. Shunt nephritis — nature of serum cryoglobulins and their relation to complement profile. J. Pediat. 88, 403. 1976.PubMedCrossRefGoogle Scholar
  135. 135.
    Strober, W., Waldman, T. A. The role of the kidney in the metabolism of plasma protein. Nephron. 13, 35. 1974.PubMedCrossRefGoogle Scholar
  136. 136.
    Tanaka, Y., Azuma, T., Hamgucki, K. Ionization and reactivities of the thiol groups which participate in the formation of interchain disulfide bonds of Bence Jones proteins and an Fab(t)fragment. J. Biochem. 83, 1249. 1978.Google Scholar
  137. 137.
    Vaughan, J. H., Jacox, R. F., Gray, B. A. Light and heavy chain components of gamma globulins in urines of normal persons and patients with agammaglobuli-nemia. J. Clin. Invest. 46, 266. 1967.PubMedCrossRefGoogle Scholar
  138. 138.
    Verroust, P. Les Lésions glomérulaires des gammopathies monoclonales et des cryoglobulinémies idiopathiques IgG-IgM. Actualites Nephrologiques dc l’Hopital, Necker. Médicales Flammarion. Paris. 167, 1971.Google Scholar
  139. 139.
    von Schéele, Ch. Light chain myeloma with features of the adult Fanconi syndrome: six years remission following one course of melpha-lan. Acta. Med. Scand. 199, 533. 1976.CrossRefGoogle Scholar
  140. 140.
    Waldmann, T. A., Strober, W., Mogielnicki, R. P. The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome or uremia. J. Clin. Invest. 51,2162. 1972.PubMedCrossRefGoogle Scholar
  141. 141.
    Waldmann, T. A., Strober, W. Renal regulation of serum protein metabolism. In: Protides of the Biological Fluids 21st Colloquium. Ed: by Peeters, H. Pergamon Press. 419. 1973.Google Scholar
  142. 142.
    Williams, R. C. Jr., Pinnell, S. R., Bratt, G. T. Low molecular weight L-chain components related to Bence Jones proteins. J. Lab. Clin. Med. 68, 81. 1966.PubMedGoogle Scholar
  143. 143.
    Winer, R. L., Cohen, A. H., Sawhney, A. S., Gorman, J. T. Sjögren syndrome with immune-complex tubulointerstitial renal disease. Clin. Immunol. Immunpath. 8, 494. 1977.CrossRefGoogle Scholar
  144. 144.
    Witts, L. J., Bladkurn, E. K., Callender, S. T. Report on the first myelomatosis trial: Part I. Analysis of presenting features of prognostic importance. Brit. J. Haemat. 24, 123. 1973.CrossRefGoogle Scholar
  145. 145.
    Wochner, R. D., Strober, W., Waldmann, T. A. The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments. J. Exp. Med. 126, 207. 1967.PubMedCrossRefGoogle Scholar
  146. 146.
    Zinneman, H. H., Levi, D., Seal, U. S. On the nature of cryoglobulins. J. Immunol. 100, 594. 1968.PubMedGoogle Scholar
  147. 147.
    Zlotnick, A., Rosenmann, E. Renal pathologic findings associated with monoclonal gammopathies. Arch. Intern. Med. 135, 40. 1975.PubMedCrossRefGoogle Scholar
  148. 148.
    Zollinger, H. V. Die pathologische Anatomie der Macroglobulinaemie Wal-denstrom. Helv. Med. Acta. 25, 153. 1958.PubMedGoogle Scholar

Copyright information

© Jákó János, Budapest 1991

Authors and Affiliations

  • János Jákó
    • 1
  1. 1.1st Department of MedicinePostgraduate Medical SchoolBudapestHungary

Personalised recommendations